U.S. Top Growth Stocks

Alnylam Pharmaceuticals

Market Cap: US$43.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Axsome Therapeutics

Market Cap: US$9.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Corcept Therapeutics

Market Cap: US$4.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Zevra Therapeutics

Market Cap: US$484.2m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Arcutis Biotherapeutics

Market Cap: US$3.3b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Atour Lifestyle Holdings

Market Cap: US$5.1b

Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.

Advanced Micro Devices

Market Cap: US$339.8b

Operates as a semiconductor company internationally.

Comstock

Market Cap: US$198.4m

Engages in the systemic decarbonization business in Nevada and internationally.

Aura Minerals

Market Cap: US$5.5b

A gold and copper production company, focuses on the development and operation of gold and base metal projects in the Americas.

T1 Energy

Market Cap: US$2.2b

Provides energy solutions for solar and batteries in the United States and Norway.

Ardelyx

Market Cap: US$1.8b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

StubHub Holdings

Market Cap: US$3.4b

Operates ticketing marketplace for live event tickets worldwide.

Legend Biotech

Market Cap: US$3.2b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

DLocal

Market Cap: US$3.9b

Operates a payment processing platform worldwide.

Bank of Marin Bancorp

Market Cap: US$437.1m

Operates as the holding company for Bank of Marin that provides a range of financial services to small to medium-sized businesses, not-for-profit organizations, and commercial real estate investors in the United States.

ARS Pharmaceuticals

Market Cap: US$991.5m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

loanDepot

Market Cap: US$716.5m

Engages in originating, financing, selling, and servicing residential mortgage loans in the United States.

BillionToOne

Market Cap: US$4.1b

A precision diagnostics company, quantifies biology to create molecular diagnostics.

FirstSun Capital Bancorp

Market Cap: US$1.1b

Operates as the bank holding company for Sunflower Bank, National Association that provides commercial and consumer banking and financial services to small and medium-sized companies in Texas, Kansas, Colorado, New Mexico, Arizona, California, and Washington.

Madrigal Pharmaceuticals

Market Cap: US$10.8b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

CVB Financial

Market Cap: US$2.9b

Operates as a bank holding company for Citizens Business Bank, a state-chartered bank that provides banking and financial services to small to mid-sized businesses and individuals.

Similarweb

Market Cap: US$404.7m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

Delcath Systems

Market Cap: US$325.1m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Pelthos Therapeutics

Market Cap: US$71.0m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

Capricor Therapeutics

Market Cap: US$1.3b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Procore Technologies

Market Cap: US$8.0b

Provides a cloud-based construction management platform and related products and services in the United States and internationally.

MP Materials

Market Cap: US$10.9b

Produces rare earth materials in the Western Hemisphere.

Workday

Market Cap: US$42.8b

Provides enterprise cloud applications in the United States and internationally.

Gorilla Technology Group

Market Cap: US$336.9m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Zscaler

Market Cap: US$26.7b

Operates as a cloud security company worldwide.

Spotify Technology

Market Cap: US$87.1b

Provides audio streaming subscription services worldwide.

Sharplink

Market Cap: US$1.4b

Operates as an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH.

CBAK Energy Technology

Market Cap: US$71.5m

CBAK Energy Technology, Inc., together with its subsidiaries, manufacture, commercialization, and distribution of standard and customized lithium and sodium batteries in Mainland China, Europe, and internationally.

Longeveron

Market Cap: US$10.9m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Kiniksa Pharmaceuticals International

Market Cap: US$3.3b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Eton Pharmaceuticals

Market Cap: US$395.8m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.